At What Stage of Pulmonary Fibrosis Do You Need Oxygen?

Most people with pulmonary fibrosis first need supplemental oxygen not at a fixed “stage” of the disease but when their blood oxygen saturation drops below specific thresholds, and that drop almost always shows up during physical activity before it appears at rest. Guidelines from the American Thoracic Society recommend long-term oxygen therapy for people with interstitial lung disease who have severe resting hypoxemia, but many patients begin using oxygen earlier, during exercise or sleep, when their levels fall into a range that limits what they can do and how they feel. The staging question is genuinely more complicated than it sounds, because pulmonary fibrosis does not follow a neat staircase of severity the way some cancers do.

Why Oxygen Levels Fall in Pulmonary Fibrosis

In a healthy lung, oxygen passes easily from the air sacs into the surrounding blood vessels. Pulmonary fibrosis replaces the thin, flexible tissue of those air sacs with thick scar tissue, which slows the transfer of oxygen into the blood. At the same time, the scarring damages and narrows the small blood vessels running through the lungs. Research using specialized diffusion measurements shows that both the thickened membrane and the loss of tiny blood vessels contribute roughly equally to the impairment in gas exchange.

1European Respiratory Review. Physiology of the lung in idiopathic pulmonary fibrosis – Section: Alterations in pulmonary gas exchange

Early on, the lung can compensate. At rest, the blood moves slowly enough through the remaining capillaries that oxygen still has time to cross the scarred membrane. But during exercise, the heart pumps blood faster, and each red blood cell spends less time next to the air sacs. That shortened contact time, combined with the thickened barrier, means oxygen cannot keep up with demand. Studies of gas exchange in idiopathic pulmonary fibrosis (IPF) found that during exercise, the contribution of impaired oxygen diffusion to low blood-oxygen levels roughly doubled compared with rest.

2PubMed. Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis

This is why “what stage do I need oxygen?” is hard to answer with a single number. Two people with the same amount of scarring on a CT scan can have very different oxygen levels, because the disease does not damage the membrane and the blood vessels in lockstep. The functional question, how well oxygen actually gets into the blood, matters more than any structural staging system alone.

Exertional Desaturation Usually Comes First

For most people with pulmonary fibrosis, the earliest sign of meaningful oxygen trouble is a drop in blood oxygen saturation during walking or climbing stairs, even while resting levels remain normal. This is called exertional desaturation, and it is one of the strongest prognostic markers in the disease. Research comparing IPF patients with other forms of interstitial lung disease found that IPF patients experience more severe oxygen drops during exercise, making early detection through walk tests especially important in that group.

3PubMed Central. Exertional Desaturation Is More Severe Than in Other Interstitial Lung Diseases

The standard tool for catching this is the six-minute walk test, where you walk as far as you can in six minutes on a flat surface while wearing a pulse oximeter. A saturation drop to 88% or below during the walk is the widely used threshold for clinically significant desaturation. A study developing a predictive score found that resting oxygen saturation and a measure of the lung’s ability to transfer carbon monoxide were the two strongest predictors of who would desaturate during the walk.

4European Respiratory Journal. Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease

Importantly, exertional desaturation is not just uncomfortable; it predicts worse outcomes. A large study of patients with fibrotic interstitial lung disease found that desaturation during the six-minute walk test was independently associated with a roughly doubled odds of the disease progressing, whether or not the patient had IPF specifically.

5Respiratory Investigation. Desaturation in the six-minute walk test predicts progressive pulmonary fibrosis in fibrotic interstitial lung disease

This is often the point at which doctors first discuss ambulatory oxygen, meaning oxygen you use during activity rather than around the clock.

The Oxygen Saturation Thresholds That Trigger a Prescription

There is no universally agreed-upon staging system that determines exactly when oxygen therapy begins. Instead, guidelines anchor the decision to measured oxygen saturation values, primarily at rest and during exertion. The American Thoracic Society’s 2020 clinical practice guideline recommends long-term oxygen therapy (at least 15 hours per day) for adults with interstitial lung disease who have severe chronic resting hypoxemia.

6American Journal of Respiratory and Critical Care Medicine. Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline – Section: Interstitial Lung Disease

“Severe resting hypoxemia” in clinical practice typically means a resting oxygen saturation consistently at or below about 88%, or a partial pressure of oxygen in the blood at or below 55 mmHg. These are the same thresholds long used for prescribing oxygen in other chronic lung diseases.

For exertional oxygen, the picture is less standardized. An international expert survey found consensus that oxygen should be recommended when patients desaturate below roughly 85 to 89% during activity, particularly if the desaturation causes symptoms or limits exercise.

7European Respiratory Journal. Oxygen in patients with fibrotic interstitial lung disease: an international Delphi survey

A Japanese research group proposed a pulse-oximetry staging system that illustrates the spectrum well. In their model, patients with resting saturation at or above 96% and no exercise desaturation were classified as the mildest stage, while those with resting saturation between 90 and 95% who also desaturated on exertion, or whose resting saturation fell below 90%, were at the most severe stage. The risk of death roughly quintupled from the mildest to the most severe category.

8Respiratory Investigation. Pulse oximetry saturation can predict prognosis of idiopathic pulmonary fibrosis

In practical terms, if your resting saturation is comfortably above 95% and you do not desaturate significantly during a walk test, oxygen therapy is unlikely to be discussed. If you desaturate into the mid-to-low 80s during exertion, ambulatory oxygen is on the table. If your resting saturation sits persistently around 88% or lower, long-term oxygen is likely needed.

What Happens During Sleep

Nighttime brings its own oxygen challenges, and these are easily overlooked. Breathing naturally becomes shallower during sleep, and in someone with already-compromised lungs, the result can be drops in oxygen saturation that are surprisingly severe. A study of IPF patients found that intermittent oxygen desaturation during sleep actually exceeded the drops seen during maximal exercise, and these nocturnal dips were independently associated with survival.

9PubMed Central. Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis

The same study found a link between the severity of sleep desaturation and elevated pressure in the blood vessels of the lungs, which itself is tied to worse outcomes. When pulmonary fibrosis coexists with pulmonary hypertension, the combination carries a worse prognosis than either condition alone.

10PubMed Central. Idiopathic pulmonary fibrosis and pulmonary hypertension: Heracles meets the Hydra

Nocturnal oxygen therapy is sometimes prescribed before a patient meets criteria for round-the-clock use, but the decision depends on overnight oximetry results, sleep study findings, and whether the patient has symptoms like morning headaches or unrefreshing sleep that suggest nighttime oxygen drops. If you have been told your daytime oxygen is fine but you feel exhausted in the morning, asking about an overnight oximetry study is reasonable.

What Supplemental Oxygen Actually Does During Exercise

One of the clearest benefits of supplemental oxygen in pulmonary fibrosis is its effect on exercise tolerance. In a controlled trial, IPF patients with exertional desaturation who breathed supplemental oxygen during exercise significantly increased their endurance time and raised their lowest oxygen saturation from about 88% to 94%, compared with breathing plain air.

11PubMed. Supplemental oxygen improves exercise capacity in IPF patients with exertional desaturation

Even IPF patients who did not have low oxygen at rest benefited. A separate trial found that oxygen supplementation improved endurance by about 99 seconds on average, reduced breathlessness, and lowered systolic blood pressure during exercise compared with air.

12PubMed. Greater endurance capacity and improved dyspnoea with acute oxygen supplementation in idiopathic pulmonary fibrosis patients without resting hypoxaemia

The reasons go beyond simply pushing more oxygen into the blood. Research using near-infrared spectroscopy to monitor the brain and leg muscles during exercise found that IPF patients breathing plain air showed a sharp decline in brain oxygenation within minutes of starting to exercise. Supplemental oxygen prevented that brain deoxygenation, improved muscle oxygenation, and reduced both breathlessness and leg fatigue.

13Respiration. Exertional Desaturation in Idiopathic Pulmonary Fibrosis: The Role of Oxygen Supplementation in Modifying Cerebral-Skeletal Muscle Oxygenation and Systemic Hemodynamics

These findings collectively explain something patients often report: that even a modest amount of supplemental oxygen during a walk or on the stairs makes them feel dramatically better, not just in their lungs but in their overall sense of energy and mental clarity.

The Complicated Picture on Quality of Life and Survival

While oxygen clearly helps people move more and breathe easier during activity, the broader evidence on quality of life and survival is more nuanced than you might expect. A systematic review of oxygen therapy in interstitial lung disease found that short-term supplemental oxygen increased exercise capacity but did not clearly reduce breathlessness during exercise across studies. Perhaps more strikingly, patients using long-term oxygen showed substantial declines in several quality-of-life measures over time.

14PubMed. Oxygen therapy for interstitial lung disease: a systematic review

That finding needs context: patients who are placed on long-term oxygen are, by definition, sicker than those who are not. Their declining quality of life reflects the progression of their disease, not necessarily an effect of the oxygen itself. An older multivariate analysis found that after adjusting for factors like age, sex, and lung function decline, oxygen therapy itself was not independently associated with worse survival.

15American Journal of Respiratory and Critical Care Medicine. Idiopathic Pulmonary Fibrosis: Impact of Oxygen and Colchicine, Prednisone, or No Therapy on Survival

A large observational study of over 16,000 IPF patients found that those on long-term oxygen had a markedly higher risk of death compared with those not on oxygen. But patients receiving both oxygen and antifibrotic medications fared better than those on oxygen alone, and patients on antifibrotics without oxygen had the lowest mortality risk.

16BMJ Open Respiratory Research. Use of supplemental oxygen therapy in idiopathic pulmonary fibrosis: an observational real-life study in 16 003 patients

The most honest reading of the evidence is that oxygen therapy is a marker of disease severity, not a proven life-extending treatment in pulmonary fibrosis the way it is in severe COPD. It is prescribed because it relieves symptoms and improves function, and because withholding it from someone with dangerously low oxygen levels would be clearly harmful. A randomized controlled trial specifically for ambulatory oxygen in fibrotic lung disease (AmbOx) found significant improvements in quality-of-life scores related to breathlessness and chest symptoms, though the psychological benefit was not statistically significant.

17The Lancet Respiratory Medicine. Ambulatory oxygen in fibrotic interstitial lung disease (AmbOx): a randomised controlled trial

Portable Devices and Delivery Options

Once oxygen is prescribed, the practical question becomes how to get it. For people using oxygen during activity, the two main portable options are small compressed-gas cylinders and portable oxygen concentrators (POCs). Concentrators are lighter and do not run out the way a cylinder does, since they pull oxygen from ambient air, but they deliver oxygen in pulses rather than continuously. A crossover trial comparing two different POC models against an oxygen cylinder during six-minute walk tests found no significant differences in nadir oxygen saturation or walking distance among the three devices.

18PubMed. Portable oxygen concentrators versus oxygen cylinder during walking in interstitial lung disease: A randomized crossover trial

That said, the interstitial lung disease population has notoriously high oxygen needs during activity, and some patients find that pulse-dose POCs cannot keep up at higher flow settings. If you find yourself still desaturating on a portable concentrator, ask your team about testing on a continuous-flow device or adjusting the pulse sensitivity. The equipment choice matters less than getting the saturation target right.

For acute crises, such as a sudden flare-up of IPF (called an acute exacerbation), standard oxygen tubing is often insufficient. High-flow nasal cannula therapy, which delivers heated, humidified oxygen at much higher rates than a standard nasal cannula, has shown promise in this setting. A cohort study found that introducing high-flow nasal cannula therapy for acute exacerbations of interstitial pneumonia was associated with lower in-hospital mortality compared with a historical period when only standard approaches were used.

19PubMed Central. Respiratory management of acute exacerbation of interstitial pneumonia using high-flow nasal cannula oxygen therapy: a single center cohort study

Practical Barriers That Keep People From Using Oxygen

Getting a prescription is one thing. Actually using the equipment consistently is another. A systematic review of qualitative studies found that fear of stigma is one of the biggest barriers to oxygen use among people with interstitial lung disease. Patients described the start of oxygen therapy as a life-changing event and voiced concerns about unwanted attention, feeling judged in public, and a shift in how they viewed themselves.

20European Respiratory Review. Barriers to and facilitators of the use of oxygen therapy in people living with an interstitial lung disease: a systematic review of qualitative evidence

Other common barriers include the physical weight and bulk of the equipment, difficulty managing tubing during daily tasks, frustration with insurance coverage and equipment suppliers, and the psychological weight of feeling tethered to a device. Some patients skip oxygen specifically when leaving the house, using it only at home, which defeats the purpose of ambulatory oxygen since the whole point is to maintain saturation during activity.

If you are avoiding your oxygen in situations where you need it most, that is worth raising with your care team. Pulmonary rehabilitation programs, which combine supervised exercise with education and peer support, can help people become more comfortable using oxygen in daily life and learn how to titrate their flow rate to different activities.

Air Travel and Altitude

Commercial aircraft cabins are pressurized to the equivalent of roughly 6,000 to 8,000 feet above sea level. For someone whose oxygen levels are already borderline, that altitude-equivalent reduction in available oxygen can push saturation well below safe levels during a flight. Even patients who do not use oxygen on the ground may need it in the air. The hypoxia altitude simulation test, which has you breathe a low-oxygen mixture while monitoring your saturation, is one way doctors evaluate whether supplemental oxygen will be necessary during a flight.

21PubMed. Hypoxia during air travel in adults with pulmonary disease

Airlines typically require advance notice and medical documentation for in-flight oxygen use, and most do not allow personal compressed-gas cylinders on board. FAA-approved portable oxygen concentrators are usually permitted, but the specifics vary by airline and change periodically. If you have pulmonary fibrosis and are planning a flight, the conversation about in-flight oxygen needs to happen with your doctor weeks before the trip, not at the gate.

When Early-Stage Patients Still Warrant Close Monitoring

One subtlety that sometimes gets lost is that patients classified as early-stage by lung function criteria may still harbor oxygen problems that predict faster progression. A study using Japan’s respiratory society staging criteria found that among patients categorized as stage I (the mildest classification), those who showed oxygen desaturation on a six-minute walk test or had higher scores on a separate prognostic index had significantly shorter times to disease progression and shorter survival than their peers without those risk factors.

22PubMed Central. Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis

This means that if you have been told your pulmonary fibrosis is mild, that does not necessarily mean your oxygen dynamics are fine. A walk test that reveals desaturation at an early stage is not just a data point for the chart; it is an argument for earlier intervention with antifibrotic therapy, closer follow-up, and potentially ambulatory oxygen. The six-minute walk test’s oxygenation data can also help define disease progression in fibrotic lung disease more broadly, independent of traditional measures like lung function decline.

23PubMed. Trajectories and Prognostic Significance of 6-Minute Walk Test Parameters in Fibrotic Interstitial Lung Disease: A Multicenter Study

The bottom line for patients at any stage is that the walk test, ideally with continuous pulse oximetry, is not optional or decorative. It is the single most accessible tool for catching the moment when supplemental oxygen can start making a real difference in daily life.